Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation.

ACS Chemical Biology
Yu WangAndrew P McMahon

Abstract

Hedgehog (Hh) signaling promotes tumorigenesis. The accumulation of the membrane protein Smoothened (Smo) within the primary cilium (PC) is a key event in Hh signal transduction, and many pharmacological inhibitors identified to date target Smo's actions. Smo ciliary translocation is inhibited by some pathway antagonists, while others promote ciliary accumulation, an outcome that can lead to a hypersensitive state on renewal of Hh signaling. To identify novel inhibitory compounds acting on the critical mechanistic transition of Smo accumulation, we established a high content screen to directly analyze Smo ciliary translocation. Screening thousands of compounds from annotated libraries of approved drugs and other agents, we identified several new classes of compounds that block Sonic hedgehog-driven Smo localization within the PC. Selective analysis was conducted on two classes of Smo antagonists. One of these, DY131, appears to inhibit Smo signaling through a common binding site shared by previously reported Smo agonists and antagonists. Antagonism by this class of compound is competed by high doses of Smo-binding agonists such as SAG and impaired by a mutation that generates a ligand-independent, oncogenic form of Smo (SmoM2)....Continue Reading

References

Mar 14, 2000·Current Opinion in Cell Biology·J P Incardona, S Eaton
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·James K ChenPhilip A Beachy
Nov 5, 2002·Genes & Development·James K ChenPhilip A Beachy
Jan 2, 2003·Current Topics in Developmental Biology·Andrew P McMahonClifford J Tabin
Mar 26, 2003·Nature Genetics·Michael K CooperPhilip A Beachy
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Feb 17, 2005·Bioorganic & Medicinal Chemistry Letters·Donna D Yu, Barry Marc Forman
Sep 2, 2005·Nature·Kevin C CorbitJeremy F Reiter
Apr 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yina LiChin Chiang
Dec 2, 2006·Nature Reviews. Drug Discovery·Lee L Rubin, Frederic J de Sauvage
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Matthias LauthRune Toftgård
Jul 21, 2007·Science·Rajat RohatgiMatthew P Scott
Feb 16, 2008·Journal of Medicinal Chemistry·Shirley A BruntonSteven Price
Feb 26, 2008·Nature Neuroscience·Young-Goo HanArturo Alvarez-Buylla
Aug 30, 2008·Nature·Robert L YauchFrederic J de Sauvage
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yu WangAndrew P McMahon
Feb 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rajat RohatgiMatthew P Scott
Mar 17, 2009·Nature Neuroscience·Jennifer A ChanRosalind A Segal
May 16, 2009·Trends in Pharmacological Sciences·Suzie J Scales, Frederic J de Sauvage
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Joel M HymanJames K Chen
Sep 4, 2009·The New England Journal of Medicine·Daniel D Von HoffJennifer A Low
Nov 17, 2009·Cell·Erich A Nigg, Jordan W Raff
Jul 7, 2011·Science Signaling·Ying SuAlan Jian Zhu
Mar 9, 2012·Nature Biotechnology·Malorye Allison

❮ Previous
Next ❯

Citations

Nov 10, 2013·Nature Medicine·Dereck AmakyeMarion Dorsch
Jan 9, 2013·Expert Opinion on Therapeutic Patents·Matthew Kyle Hadden
May 23, 2014·Expert Opinion on Drug Discovery·Upasana Banerjee, Matthew Kyle Hadden
May 23, 2015·International Journal of Oncology·Ashley L SpannAndra R Frost
Dec 17, 2014·Cell Cycle·Mary Mazzotta Heckler, Rebecca B Riggins
Mar 3, 2015·Expert Opinion on Therapeutic Patents·Minhang Xin
Aug 28, 2012·Chemistry & Biology·Yu WangAndrew P McMahon
May 23, 2014·Seminars in Cell & Developmental Biology·Saikat Mukhopadhyay, Rajat Rohatgi
Feb 4, 2014·Biochemical and Biophysical Research Communications·Hanne Roberg-LarsenSteven Ray Wilson
Aug 11, 2016·Nuclear Receptor Signaling·Shailaja D DivekarRebecca B Riggins
Aug 28, 2019·Angewandte Chemie·Lea KremerHerbert Waldmann
Jan 4, 2020·Regenerative Medicine Research·Lu ZhengYing Xiao
Oct 2, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Deanna M TiekRebecca B Riggins
Apr 10, 2021·Seminars in Cancer Biology·Jin Jiang
May 9, 2021·Biochemical Pharmacology·Su-Fen WeiYong-Qiang Liu
Jun 4, 2013·Journal of the American Chemical Society·Giannina I SchaeferStuart L Schreiber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Yu WangAndrew P McMahon
Proceedings of the National Academy of Sciences of the United States of America
Rajat RohatgiMatthew P Scott
Proceedings of the National Academy of Sciences of the United States of America
Joel M HymanJames K Chen
© 2021 Meta ULC. All rights reserved